This case study describes how a 130+ year global biopharma company overcame scalability, governance, and cost-transparency issues created by a shared AWS DevOps account where multiple projects competed for access, permissions were complex, architecture choices were constrained, and a single-region setup limited expansion. Brillio introduced a Platform per Project model that gives each project a dedicated, fully automated environment with clear ownership, faster provisioning, multi-region capability, real-time cost tracking, SSO, flexible networking, and automated lifecycle decommissioning to reduce overhead and unallocated spend. The approach used workshops and pilots to standardize platform types, automation workflows, and governance, cutting provisioning time from weeks to minutes and ac

Join for free to read